AV

Abdul Vahid Abdul Hamid Shaikh

Active Director Director DIN 08075018
DIN 08075018 First appointment Feb 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdul Vahid Abdul Hamid Shaikh

Data last updated:

Abdul Vahid Abdul Hamid Shaikh is a Director at Fazzer Pharmaceutical Private Limited (since 2018). The company operates in Pharma.

DIN 08075018
Primary Designation Director
Industry Pharma
First Appointment 26 Feb 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Feb 20182018Active

Board colleagues of Abdul Vahid Abdul Hamid Shaikh

Directorship timeline

Open interactive timeline →
Fazzer Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Abdul Vahid Abdul Hamid Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Vahid Abdul Hamid Shaikh

Abdul Vahid Abdul Hamid Shaikh currently holds 1 directorship: Fazzer Pharmaceutical Private Limited (Director, since 26 Feb 2018).

Abdul Vahid Abdul Hamid Shaikh was first appointed on 26 Feb 2018 as Director at Fazzer Pharmaceutical Private Limited.

The current boards of Abdul Vahid Abdul Hamid Shaikh's companies include Aslam Aajij Shaikh (Fazzer Pharmaceutical Private Limited), Juned Ahmad (Fazzer Pharmaceutical Private Limited), Saeed Abdul Hameed Shaikh (Fazzer Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available